Treatment of patients with acquired inhibitors [5]

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 3, 2005, Pages 595-597

  Sallah, Sabah ^a   Aledort, L ^b  

^a NOVO NORDISK A S   (Denmark)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; CLADRIBINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNE DISEASE; DISEASE SEVERITY; DRUG EFFICACY; HEMARTHROSIS; HEMOPHILIA; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; PUERPERIUM; BLOOD; HEMOPHILIA A; IMMUNOLOGY; PRACTICE GUIDELINE;

AUTOANTIBODIES; FACTOR VIII; HEMOPHILIA A; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PRACTICE GUIDELINES;

EID: 23944461153     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01149.x     Document Type: Letter

References (19)

1. Zakarija A, Green D. Acquired hemophilia: diagnosis and management. Curr Hematol Rep 2002; 1: 27-33.
2. Kessler CM, Nemes L. Acquired inhibitors to factor VIII. In: Rodriquez-Merchan EC, Lee CA, eds. Inhibitors in Patients with Haemophilia. Malden, MA: Blackwell Science Ltd, 2002: 98-112.
3. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200-3.
4. Stasi R, Brunetti M, Stipa E, Amadori S. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood 2004; 103: 4424-8.
5. Bossi P, Cabane J, Ninet J, Dhote R, Hanslik T, Chosidow O, Jouan-Flahault C, Horellou MH, Leynadier F, Liozon E, Pouchot J, Robin JP, Sanderson F, Schaeffer A, Sicard D, Staikowsky F, Wechsler B, Zittoun R. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998; 105: 400-8.
6. Morrison AE, Ludlam CA, Kessler CM. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 1993; 81: 1513-20.
7. Sallah S, Wan JY. Inhibitors against factor VIII in patients with cancer: analysis of 41 patients. Cancer 2001; 91: 1067-74.
8. Sallah S, Wan J. Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine. Thromb Haemost 2001; 86: 1119-21.
9. Hay CRM, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78: 1463-7.
10. Sallah S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 2004; 10: 169-73.
11. Slocombe GW, Newland AC, Colvin MP, Colvin BT. The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII. Br J Haematol 1981; 47: 577-85.
12. Freedman J, Rand ML, Russell O, Davis C, Cheatley PL, Blanchette V, Garvey MB. Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII. Transfusion 2003; 43: 1508-13.
13. Toepfer M, Rommel F, Sitter T, Spannagl M, Held E, Schramm W, Schiffl H. Reduction of acquired high titer factor VIII antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy. Thromb Haemost 1998; 80: 1035-6.
14. Négrier C, Dechavanne M, Alfonsi F, Tremisi PJ. Successful treatment of acquired factor VIII antibody by extracorporeal immunoadsoption. Acta Haematol 1991; 85: 107-10.
15. Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of individuals with factor VIII antibodies. Thromb Haemost 1993; 70: 753-7.
16. Wiestner A, Cho HJ, Asch AS, Michelis MA, Zeller JA, Peerschke EI, Weksler BB, Schechber GP. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002; 100: 3426-2428.
17. Sallah S, Wan J. Efficacy of 2-CDA in refractory factor VIII inhibitors in persons without inhibitors. Blood 2003; 101: 943-5.
18. Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A Prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1995; 86: 797-804.
19. Hauser I, Schneider B, Leckner K. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 1995; 73: 1-5.